Based upon the reasoning that protein-carbohydrate recognition is invo
lved in diverse intercellular activities including growth control and
cell motility 14 probes have been employed to characterize epitope pre
sence in sections of 80 cases with operated lung carcinomas, 20 patien
ts with mesothelioma, and 20 cases with non-malignant lung diseases. A
s parts of the innate immune system with supposed relevance for host d
efense the mannan-binding lectin (MBL) and serum amyloid P component (
SAP) were employed. The naturally occurring immunoglobulin G fractions
with selectivity for alpha-galactosides (alpha(+)) and beta-galactosi
des (beta(+)) and their subfractions with enhanced target selectivity
(alpha(+)beta(-),alpha(-)beta(+)) allowed the monitoring of expression
of reactive sites for these autoantibodies as a step to elucidate pot
ential anti-tumor activity. Due to the diversity of cellular galactosi
de-containing glycoconjugates two galectins and a plant lectin were in
cluded. As a measure of receptor activities for carbohydrates, neoglyc
oconjugates with alpha-galactose, the B-disaccharide, the Forssman-dis
accharide, and alpha-glucose as histochemically crucial ligand part we
re tested in addition to an antibody against heparin-binding lectin. Q
uantitative image analysis revealed significant differences between ca
ses with small cell and non-small cell lung cancer for the plant lecti
n and one galectin, cases with non-tumorous lung disease and lung carc
inoma for serum amyloid P component and the beta-galactoside-selective
autoantibody fraction. Prognostic relevance was observed for the pres
ence of glucose-specific sites in small cell lung cancer and meso-thel
ioma cases, and of galectin- and alpha-galactoside-selective immunoglo
bulin G fraction-binding sites in non-small cell lung cancer patients.